| Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis J Rosendahl, H Witt, R Szmola, E Bhatia, B Ózsvári, O Landt, HU Schulz, ... Nature genetics 40 (1), 78-82, 2008 | 507 | 2008 |
| Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease R Lamb, B Ozsvari, CL Lisanti, HB Tanowitz, A Howell, ... Oncotarget 6 (7), 4569, 2015 | 500 | 2015 |
| Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells A De Luca, M Fiorillo, M Peiris-Pagès, B Ozsvari, DL Smith, ... Oncotarget 6 (17), 14777, 2015 | 257 | 2015 |
| Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via “differentiation-based nano-therapy” M Fiorillo, AF Verre, M Iliut, M Peiris-Pagés, B Ozsvari, R Gandara, ... Oncotarget 6 (6), 3553, 2015 | 227 | 2015 |
| Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity FC Weber, T Németh, JZ Csepregi, A Dudeck, A Roers, B Ozsvári, ... Journal of Experimental Medicine 212 (1), 15-22, 2015 | 183 | 2015 |
| Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells L Kiss, FR Walter, A Bocsik, S Veszelka, B Ózsvári, LG Puskás, ... Journal of pharmaceutical sciences 102 (4), 1173-1181, 2013 | 136 | 2013 |
| Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling R Lamb, G Bonuccelli, B Ozsvári, M Peiris-Pagès, M Fiorillo, DL Smith, ... Oncotarget 6 (31), 30453, 2015 | 134 | 2015 |
| Effects of bile acids on pancreatic ductal bicarbonate secretion in guinea pig V Venglovecz, Z Rakonczay, B Ozsvari, T Takacs, J Lonovics, A Varro, ... Gut 57 (8), 1102-1112, 2008 | 126 | 2008 |
| Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy R Lamb, M Fiorillo, A Chadwick, B Ozsvari, KJ Reeves, DL Smith, ... Oncotarget 6 (16), 14005, 2015 | 111 | 2015 |
| Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts B Ozsvari, JR Nuttall, F Sotgia, MP Lisanti Aging (Albany NY) 10 (11), 3294, 2018 | 109 | 2018 |
| Trypsin reduces pancreatic ductal bicarbonate secretion by inhibiting CFTR Cl− channels and luminal anion exchangers P Pallagi, V Venglovecz, Z Rakonczay Jr, K Borka, A Korompay, B Ózsvári, ... Gastroenterology 141 (6), 2228-2239. e6, 2011 | 96 | 2011 |
| The effect of sucrose esters on a culture model of the nasal barrier L Kürti, S Veszelka, A Bocsik, NTK Dung, B Ózsvári, LG Puskás, Á Kittel, ... Toxicology in Vitro 26 (3), 445-454, 2012 | 65 | 2012 |
| Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction R Lamb, H Harrison, DL Smith, PA Townsend, T Jackson, B Ozsvari, ... Oncotarget 6 (7), 4585, 2015 | 62 | 2015 |
| Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy B Ozsvari, G Bonuccelli, R Sanchez-Alvarez, R Foster, F Sotgia, ... Aging (Albany NY) 9 (12), 2610, 2017 | 61 | 2017 |
| Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity G Bonuccelli, M Peiris-Pages, B Ozsvari, UE Martinez-Outschoorn, ... Oncotarget 8 (6), 9868, 2017 | 57 | 2017 |
| Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells LG Puskás, LZ Fehér, C Vizler, F Ayaydin, E Rásó, E Molnár, I Magyary, ... Lipids in health and disease 9, 1-9, 2010 | 55 | 2010 |
| The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo L Hackler Jr, B Ózsvári, M Gyuris, P Sipos, G Fábián, E Molnár, A Marton, ... PloS one 11 (3), e0149832, 2016 | 54 | 2016 |
| Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells R Lamb, B Ozsvari, G Bonuccelli, DL Smith, RG Pestell, ... Oncotarget 6 (26), 21892, 2015 | 54 | 2015 |
| A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX F Sotgia, B Ozsvari, M Fiorillo, EM De Francesco, G Bonuccelli, MP Lisanti Cell Cycle 17 (17), 2091-2100, 2018 | 53 | 2018 |
| Sucrose Esters Increase Drug Penetration, But Do Not Inhibit P‐Glycoprotein in Caco‐2 Intestinal Epithelial Cells L Kiss, É Hellinger, AM Pilbat, Á Kittel, Z Török, A Füredi, G Szakács, ... Journal of Pharmaceutical Sciences 103 (10), 3107-3119, 2014 | 52 | 2014 |
Michael P. Lisanti, MD-PhD, FRSA, FR...Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)E-mail megerősítve itt: salford.ac.uk
